Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Beam Therapeutics Inc. | beam-ex322_6.htm |
| EX-32.1 - EX-32.1 - Beam Therapeutics Inc. | beam-ex321_7.htm |
| EX-31.2 - EX-31.2 - Beam Therapeutics Inc. | beam-ex312_9.htm |
| EX-31.1 - EX-31.1 - Beam Therapeutics Inc. | beam-ex311_8.htm |
| EX-21.1 - EX-21.1 - Beam Therapeutics Inc. | beam-ex211_29.htm |
| EX-4.3 - EX-4.3 - Beam Therapeutics Inc. | beam-ex43_74.htm |
| 10-K - 10-K - Beam Therapeutics Inc. | beam-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-236582 on Form S-8 of our report dated March 30, 2020, relating to the financial statements of Beam Therapeutics Inc. and subsidiaries appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 30, 2020